Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-006910

Options or other derivatives

  • Executive Chairman acquired 525,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Reich Samuel J Executive Chairman 2023-03-14 Grant or award · Employee Stock Option (right to buy) +525,000 525,000 D
Loading xslF345X03/rdgdoc.xml…